Neoadjuvant chemotherapy alone with mFOLFOXIRI in locally advanced rectal cancer: A single-arm phase II study.

被引：0

作者：

Deng, Yanhong ^{[1
]}

Zhang, Jianwei ^{[1
]}

Cai, Yue ^{[1
]}

Hu, Huabin ^{[1
]}

Ling, Jiayu ^{[1
]}

Xiao, Jian ^{[1
]}

Huang, Meijin ^{[1
]}

Kang, Liang ^{[1
]}

Wang, Lei ^{[1
]}

Lan, Ping ^{[1
]}

Wang, Jianping ^{[1
]}

机构：

[1] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou 510275, Guangdong, Peoples R China

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期

关键词：

D O I：

10.1200/jco.2016.34.4_suppl.tps783

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS783

引用

页数：1

共 50 条

[21] The efficacy and safety of neoadjuvant mFOLFOXIRI and XELOX for locally advanced rectal cancer: A retrospective study
Kodama, Hiroyuki
Terazawa, Tetsuji
Yukami, Hiroki
Aoki, Masahiko
Asaishi, Ken
Yamaguchi, Toshifumi
Kii, Takayuki
Goto, Masahiro
Tanaka, Keitarou
Okuda, Jyunji
Higuchi, Kazuhide
ANNALS OF ONCOLOGY, 2019, 30
[22] Neoadjuvant chemotherapy with FOLFOXIRI for high-risk relapsed locally advanced colon cancer: A single-arm phase II trial.
Meng, Wenjian
Qiu, Meng
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 201 - 201
[23] Neoadjuvant tislelizumab plus chemotherapy among patients with advanced ovarian cancer: A prospective, single-arm, phase II study
Zhou, Jinhua
Liu, Wei
Huang, Yazhen
Ding, Hongmei
Chen, Youguo
GYNECOLOGIC ONCOLOGY, 2024, 190 : S298 - S299
[24] Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer
Pant, Shubham
Moyers, Justin T.
Naing, Aung
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (11)
[25] Weekly paclitaxel and cisplatin as neoadjuvant chemotherapy with locally advanced breast cancer: a prospective, single arm, phase II study
Zhou, Liheng
Xu, Shuguang
Yin, Wenjin
Lin, Yanpin
Du, Yueyao
Jiang, Yiwei
Wang, Yaohui
Zhang, Jie
Wu, Ziping
Lu, Jinsong
ONCOTARGET, 2017, 8 (45) : 79305 - 79314
[26] The DUREC trial: Durvalumab plus total neoadjuvant therapy in locally advanced rectal cancer - a multicenter, single-arm, phase II study (GEMCAD-1703)
Capdevila Castillon, J.
Alonso, V.
Macias Declara, I.
Melian, M.
Gallego Plazas, J.
Vera, R.
Riesco Martinez, M. C.
Maurel, J.
Grana Suarez, B.
Hernando, J.
Garcia Alvarez, A.
Navalpotro, B.
Soler Gonzalez, G.
Polo, E.
Garcia Fadrique, A.
Espin, E.
Fernandez Martos, C.
Villacampa Javierre, G.
Losa, F.
ANNALS OF ONCOLOGY, 2023, 34 : S430 - S431
[27] A multicenter single-arm phase II study examining the efficacy of TNT for locally advanced rectal cancer: ENSEMBLE-2.
Ando, Koji
Kagawa, Yoshinori
Uemura, Mamoru
Watanabe, Jun
Miyo, Masaaki
Emi, Yasunori
Matsuhashi, Nobuhisa
Izawa, Naoki
Muto, Osamu
Kinjo, Tatsuya
Nishizawa, Yujiro
Hata, Tsuyoshi
Suwa, Yusuke
Honboh, Takuya
Tajima, Jesse Yu
Sunakawa, Yu
Oba, Koji
Takemasa, Ichiro
Oki, Eiji
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[28] Importance of the neoadjuvant rectal (NAR) score to the outcome of neoadjuvant chemotherapy alone for locally advanced rectal cancer
Toshiki Mukai
Keisuke Uehara
Toshisada Aiba
Atsushi Ogura
Toyonori Tsuzuki
Aya Tanaka
Masanori Sando
Noriyuki Ohara
Yusuke Sato
Norifumi Hattori
Goro Nakayama
Yasuhiro Kodera
Masato Nagino
Surgery Today, 2020, 50 : 912 - 919
[29] Importance of the neoadjuvant rectal (NAR) score to the outcome of neoadjuvant chemotherapy alone for locally advanced rectal cancer
Mukai, Toshiki
Uehara, Keisuke
Aiba, Toshisada
Ogura, Atsushi
Tsuzuki, Toyonori
Tanaka, Aya
Sando, Masanori
Ohara, Noriyuki
Sato, Yusuke
Hattori, Norifumi
Nakayama, Goro
Kodera, Yasuhiro
Nagino, Masato
SURGERY TODAY, 2020, 50 (08) : 912 - 919
[30] Early response to upfront neoadjuvant chemotherapy (CAPOX) alone in low- and intermediate-risk rectal cancer: a single-arm phase II trial
Deng, Xiangbing
Wu, Qingbin
Bi, Liang
Yu, Yongyang
Huang, Shuo
He, Du
Wu, Bing
Gou, Hongfeng
Meng, Wenjian
Qiu, Meng
He, Yazhou
Wang, Ziqiang
BRITISH JOURNAL OF SURGERY, 2022, 109 (01) : 121 - 128

← 1 2 3 4 5 →